119th Congress · introduced in the House · Sep 30, 2025
Restoring Safeguards for Dangerous Abortion Drugs Act
Official title from Congress.gov
Latest action (Sep 30, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
7 citations.
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Pharmacy
$420,000
Spent on own lobbying
Shield Laws Chemical abortion drugs S. 1631, H. R. 5646 - Restoring Safeguards for Dangerous Abortion Drugs Act H.R. 679 - To nullify the modifications made by the Food and Drug Administration in January 2023 to the…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL WOMEN'S LAW CENTER ACTION FUND · lobbying firm or registrant: NATIONAL WOMEN'S LAW CENTER ACTION FUND
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Family issues/Abortion/Adoption
$85,000
Spent on own lobbying
…t (S. 2556, H.R. 4849) (House and Senate) Advocacy for Momnibus Act (H.R. 7973) (House) Advocacy against Restoring Safeguards for Dangerous Abortion Drugs Act (H.R. 5646, S. 1631) (House and Senate) Advocacy against Pregnant Students' Rights Act (H.R.6359, S.3627) (House and Senate) Advocacy for veterans' abortion access (HJ Re…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Family issues/Abortion/Adoption
$380,000
Spent on own lobbying
…rtion Prevention and Accountability Act; Patient Protection and Affordable Care Act; Abortion funding; IVF issues; National Defense Authorization Act; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Food and Drug…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Pharmacy
$380,000
Spent on own lobbying
Shield Laws Chemical abortion drugs S. 1631, H. R. 5646 - Restoring Safeguards for Dangerous Abortion Drugs Act H.R. 679 - To nullify the modifications made by the Food and Drug Administration in January 2023 to the…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Family issues/Abortion/Adoption
$420,000
Spent on own lobbying
…Construction and Veterans Affairs, and Extensions Act; Contraception issues; IVF issues; National Defense Authorization Act; Supreme Court Decisions; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Food and Drug…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Pharmacy
$420,000
Spent on own lobbying
Shield Laws; Chemical abortion drugs; H.R. 5485 Second Chance at Life Act of 2025; Supreme Court Decisions; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; H.R. 629 Ending Chemical Abortions Act; H.R. 679 To nullify the modifications made by the Food and Drug…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN B ANTHONY LIST · lobbying firm or registrant: SUSAN B ANTHONY LIST
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Family issues/Abortion/Adoption
$360,000
Spent on own lobbying
…ood and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing